- Home
- PACS
as 01-17-2025 4:00pm EST
Stocks
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | FARMINGTON |
| Market Cap: | 2.1B | IPO Year: | 2024 |
| Target Price: | $33.22 | AVG Volume (30 days): | 602.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.68 | EPS Growth: | 82.79 |
| 52 Week Low/High: | $12.54 - $43.92 | Next Earning Date: | 02-16-2025 |
| Revenue: | $3,558,953,000 | Revenue Growth: | 205.08% |
| Revenue Growth (this year): | 29.04% | Revenue Growth (next year): | 18.31% |
Latest PACS Group Inc. Common Stock News
PACS Breaking Stock News: Dive into PACS Ticker-Specific Updates for Smart Investing
TipRanks
12 days ago
Pacs Group price target lowered to $32 from $46 at Truist
Business Wire
a month ago
PACS Group Completes Acquisition of Skilled Nursing Facilities in Tennessee
Business Wire
2 months ago
PACS Group Announces Receipt of Notice of Late Filing from NYSE
Business Wire
2 months ago
U.S. News & World Report Honors 36 PACS Communities
TipRanks
2 months ago
Pacs Group price target lowered to $31 from $48 at Stephens
Business Wire
2 months ago
Seventeen PACS Post Acute Locations Honored by Newsweek Magazine
TipRanks
2 months ago
Pacs Group resumed with an Overweight at JPMorgan
Business Wire
2 months ago
PACS Group Provides Preliminary Third Quarter Operational Metrics
Compare PACS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PACS PACS Group Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.